Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control. / Ásbjörnsdóttir, Björg; Vestgaard, Marianne; Do, Nicoline C.; Ringholm, Lene; Andersen, Lise L.T.; Jensen, Dorte M.; Damm, Peter; Mathiesen, Elisabeth R.
I: Diabetic Medicine, Bind 38, Nr. 3, e14506, 2021.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes and the impact on glycaemic control
AU - Ásbjörnsdóttir, Björg
AU - Vestgaard, Marianne
AU - Do, Nicoline C.
AU - Ringholm, Lene
AU - Andersen, Lise L.T.
AU - Jensen, Dorte M.
AU - Damm, Peter
AU - Mathiesen, Elisabeth R.
PY - 2021
Y1 - 2021
N2 - Aims: To study the prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes compared with pregnant women without diabetes. Secondly, to explore whether anxiety and/or depression symptoms in early pregnancy have an impact on glycaemic control and gestational weight gain. Methods: A prospective cohort study of 90 consecutive singleton pregnant women with type 2 diabetes and 88 singleton pregnant women without diabetes. All women completed the Hospital Anxiety and Depression Scale questionnaire in early and late pregnancy. A score ≥8 in the anxiety or the depression scale was used to define anxiety and/or depression symptoms. Results: Anxiety and/or depression symptoms were present in 40% of women with type 2 diabetes and 7% of women without diabetes in early pregnancy (Relative Risk = 5.87 (95% Confidence Interval: 2.60–13.22)). The figures were similar in late pregnancy. In women with type 2 diabetes and anxiety and/or depression symptoms in early pregnancy, HbA1c (mean ± SD) was 52 ± 14 vs. 49 ± 11 mmol/mol (6.9 ± 1.2 vs. 6.6 ± 1.0%), p = 0.31 in early pregnancy and 43 ± 8 vs. 40 ± 4 mmol/mol (6.1 ± 0.7 vs. 5.8 ± 0.4%), p = 0.04 in late pregnancy compared with women without symptoms. Gestational weight gain was similar in both groups. Conclusions: In women with type 2 diabetes, 40% had anxiety and/or depression symptoms in early pregnancy. Women with these symptoms obtained less optimal glycaemic control in late pregnancy but similar gestational weight gain as the remaining women.
AB - Aims: To study the prevalence of anxiety and depression symptoms in pregnant women with type 2 diabetes compared with pregnant women without diabetes. Secondly, to explore whether anxiety and/or depression symptoms in early pregnancy have an impact on glycaemic control and gestational weight gain. Methods: A prospective cohort study of 90 consecutive singleton pregnant women with type 2 diabetes and 88 singleton pregnant women without diabetes. All women completed the Hospital Anxiety and Depression Scale questionnaire in early and late pregnancy. A score ≥8 in the anxiety or the depression scale was used to define anxiety and/or depression symptoms. Results: Anxiety and/or depression symptoms were present in 40% of women with type 2 diabetes and 7% of women without diabetes in early pregnancy (Relative Risk = 5.87 (95% Confidence Interval: 2.60–13.22)). The figures were similar in late pregnancy. In women with type 2 diabetes and anxiety and/or depression symptoms in early pregnancy, HbA1c (mean ± SD) was 52 ± 14 vs. 49 ± 11 mmol/mol (6.9 ± 1.2 vs. 6.6 ± 1.0%), p = 0.31 in early pregnancy and 43 ± 8 vs. 40 ± 4 mmol/mol (6.1 ± 0.7 vs. 5.8 ± 0.4%), p = 0.04 in late pregnancy compared with women without symptoms. Gestational weight gain was similar in both groups. Conclusions: In women with type 2 diabetes, 40% had anxiety and/or depression symptoms in early pregnancy. Women with these symptoms obtained less optimal glycaemic control in late pregnancy but similar gestational weight gain as the remaining women.
KW - anxiety
KW - depression
KW - gestational weight gain
KW - pregnancy
KW - pregnancy outcome
KW - type 2 diabetes
U2 - 10.1111/dme.14506
DO - 10.1111/dme.14506
M3 - Journal article
C2 - 33368557
AN - SCOPUS:85099047883
VL - 38
JO - Diabetic Medicine
JF - Diabetic Medicine
SN - 0742-3071
IS - 3
M1 - e14506
ER -
ID: 255458381